Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential ...

Three years ago, if you had asked any security professional or KYC specialist in the financial services industry about the ...

Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer ...

Amini: I believe this is critical for all stages of NSCLC. Whether you are in a small rural practice, large community or ...

Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.

Have you had a peak experience lately, replete with great happiness and personal fulfillment? If so, you've probably found ...

Build strength, power and a leaner physique in the same workout ...

PharmTech spoke with Andrew Mitchell, associate vice president of Business Development at BioVectra, about which 2025 trends will continue to impact the pharma industry and how CDMOs can offer ...

Some argue that AI cannot be a good therapist because it is mindless. Perhaps it is AI's distinct kind of mind that poses the ...

The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, ...

Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global ...

Not long ago, recovery was an afterthought. Now it’s the game.